AU1926595A - Pharmaceutical formulations of ciliary neurotrophic factor - Google Patents

Pharmaceutical formulations of ciliary neurotrophic factor

Info

Publication number
AU1926595A
AU1926595A AU19265/95A AU1926595A AU1926595A AU 1926595 A AU1926595 A AU 1926595A AU 19265/95 A AU19265/95 A AU 19265/95A AU 1926595 A AU1926595 A AU 1926595A AU 1926595 A AU1926595 A AU 1926595A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulations
neurotrophic factor
ciliary neurotrophic
ciliary
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19265/95A
Inventor
Thomas Calderwood
Leo Gu
Victoria Knepp
Anna Muchnik
John Whatley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex Synergen Neuroscience Joint Venture
Original Assignee
Syntex USA LLC
Syntex Synergen Neuroscience Joint Venture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC, Syntex Synergen Neuroscience Joint Venture filed Critical Syntex USA LLC
Publication of AU1926595A publication Critical patent/AU1926595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU19265/95A 1994-02-22 1995-02-21 Pharmaceutical formulations of ciliary neurotrophic factor Abandoned AU1926595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19977194A 1994-02-22 1994-02-22
US199771 1994-02-22
PCT/US1995/002194 WO1995022342A1 (en) 1994-02-22 1995-02-21 Pharmaceutical formulations of ciliary neurotrophic factor

Publications (1)

Publication Number Publication Date
AU1926595A true AU1926595A (en) 1995-09-04

Family

ID=22738959

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19265/95A Abandoned AU1926595A (en) 1994-02-22 1995-02-21 Pharmaceutical formulations of ciliary neurotrophic factor

Country Status (2)

Country Link
AU (1) AU1926595A (en)
WO (1) WO1995022342A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313089B1 (en) 1997-08-20 2001-11-06 Duke University Complexes of apolipoprotein E and ciliary neurotrophic factor (CNTF) and methods of use
KR100522188B1 (en) 2003-01-20 2005-10-18 주식회사 뉴로테크 Method for inhibition of necrosis induced by neurotrophin
KR100852962B1 (en) 2007-11-12 2008-08-20 주식회사 뉴로테크 Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5218094A (en) * 1986-08-07 1993-06-08 Fidia, S.P.A. Neuronotrophic factor derived from mammalian brain tissue
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor

Also Published As

Publication number Publication date
WO1995022342A1 (en) 1995-08-24

Similar Documents

Publication Publication Date Title
AU7572196A (en) Pharmaceutical formulations
EG23826A (en) Pharmaceutical formulations
GB9408117D0 (en) Pharmaceutical formulations
AU6995396A (en) Pharmaceutical formulation
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
ZA951781B (en) Pharmaceutical formulations
AU6973396A (en) Pharmaceutical formulation
GB9405856D0 (en) Pharmaceutical formulation
AU1847695A (en) Pharmaceutical formulations of cntf
AU2531295A (en) Pharmaceutical composition
AU7582696A (en) Pharmaceutical formulation
AU1282895A (en) Novel human ciliary neurotrophic factor
ZA96526B (en) Novel pharmaceutical formulation
AU1475595A (en) Pharmaceutical preparation
AU1926595A (en) Pharmaceutical formulations of ciliary neurotrophic factor
AU1427895A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
ZA96392B (en) Pharmaceutical formulations
AU5263596A (en) Pharmaceutical formulations of (rhizophora mangle l)
GB9413542D0 (en) Pharmaceutical formulations
GB9500978D0 (en) Pharmaceutical formulations
AU4948297A (en) Pharmaceutical preparation
AU4415296A (en) Processes of preparing pharmaceutical compositions
AU6933794A (en) Pharmaceutical formulations